VERTEX PHARMACEUTICALS INC / MA Capital Expenditures
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Capital Expenditures of $245.60 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-04
- VERTEX PHARMACEUTICALS INC / MA payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $112.20M, a 22.99% decline year-over-year.
- VERTEX PHARMACEUTICALS INC / MA payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $133.40M, a 227.76% increase year-over-year.
- VERTEX PHARMACEUTICALS INC / MA payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $149.40M, a 61.34% increase year-over-year.
- VERTEX PHARMACEUTICALS INC / MA payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $101.80M, a 50.37% increase year-over-year.
- VERTEX PHARMACEUTICALS INC / MA payments to acquire property, plant, and equipment for fiscal 2025 was $437.60M, a 46.99% increase from fiscal 2024.
- VERTEX PHARMACEUTICALS INC / MA payments to acquire property, plant, and equipment for fiscal 2024 was $297.70M, a 48.55% increase from fiscal 2023.
- VERTEX PHARMACEUTICALS INC / MA payments to acquire property, plant, and equipment for fiscal 2023 was $200.40M, a 2.10% decline from fiscal 2022.
- VERTEX PHARMACEUTICALS INC / MA payments to acquire property, plant, and equipment for fiscal 2022 was $204.70M, a 12.89% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 3 month as first filed | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $112.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $245.60M 10-Q · filed 2026-08-04 | $395.00M derived: sum of 3 quarters · filed 2026-08-04 | $496.80M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $133.40M 10-Q · filed 2026-05-05 | $282.80M derived: sum of 2 quarters · filed 2026-05-05 | $384.60M derived: sum of 3 quarters · filed 2026-05-05 | $530.30M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $149.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $251.20M derived: sum of 2 quarters · filed 2026-02-13 | $396.90M derived: sum of 3 quarters · filed 2026-08-04 | $437.60M 10-K · filed 2026-02-13 | ||||
| 2025-09-30 | $101.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $247.50M derived: sum of 2 quarters · filed 2026-08-04 | $288.20M 10-Q · filed 2025-11-04 | $380.80M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $145.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $186.40M 10-Q · filed 2026-08-04 | $279.00M derived: sum of 3 quarters · filed 2026-08-04 | $346.70M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $40.70M 10-Q · filed 2026-05-05 | $133.30M derived: sum of 2 quarters · filed 2026-05-05 | $201.00M derived: sum of 3 quarters · filed 2026-05-05 | $270.00M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $92.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $160.30M derived: sum of 2 quarters · filed 2026-02-13 | $229.30M derived: sum of 3 quarters · filed 2026-02-13 | $297.70M 10-K · filed 2026-02-13 | ||||
| 2024-09-30 | $67.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $136.70M derived: sum of 2 quarters · filed 2025-11-04 | $205.10M 10-Q · filed 2025-11-04 | $263.20M derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-06-30 | $69.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $137.40M 10-Q · filed 2025-08-05 | $195.50M derived: sum of 3 quarters · filed 2026-02-13 | $236.10M derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-03-31 | $68.40M 10-Q · filed 2025-05-06 | $126.50M derived: sum of 2 quarters · filed 2026-02-13 | $167.10M derived: sum of 3 quarters · filed 2026-02-13 | $226.70M derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2023-12-31 | $58.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $98.70M derived: sum of 2 quarters · filed 2026-02-13 | $158.30M derived: sum of 3 quarters · filed 2026-02-13 | $200.40M 10-K · filed 2026-02-13 | ||||
| 2023-09-30 | $40.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $100.20M derived: sum of 2 quarters · filed 2024-11-05 | $142.30M 10-Q · filed 2024-11-05 | $175.90M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-06-30 | $59.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $101.70M 10-Q · filed 2024-08-02 | $135.30M derived: sum of 3 quarters · filed 2025-02-13 | $189.50M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-03-31 | $42.10M 10-Q · filed 2024-05-07 | $75.70M derived: sum of 2 quarters · filed 2025-02-13 | $129.90M derived: sum of 3 quarters · filed 2025-02-13 | $183.20M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2022-12-31 | $33.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $87.80M derived: sum of 2 quarters · filed 2025-02-13 | $141.10M derived: sum of 3 quarters · filed 2025-02-13 | $204.70M 10-K · filed 2025-02-13 | ||||
| 2022-09-30 | $54.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $107.50M derived: sum of 2 quarters · filed 2023-11-07 | $171.10M 10-Q · filed 2023-11-07 | $232.90M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-06-30 | $53.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $116.90M 10-Q · filed 2023-08-02 | $178.70M derived: sum of 3 quarters · filed 2024-02-15 | $231.10M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-03-31 | $63.60M 10-Q · filed 2023-05-02 | $125.40M derived: sum of 2 quarters · filed 2024-02-15 | $177.80M derived: sum of 3 quarters · filed 2024-02-15 | $227.70M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2021-12-31 | $61.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $114.20M derived: sum of 2 quarters · filed 2024-02-15 | $164.10M derived: sum of 3 quarters · filed 2024-02-15 | $235.00M 10-K · filed 2024-02-15 | ||||
| 2021-09-30 | $52.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $102.30M derived: sum of 2 quarters · filed 2022-10-28 | $173.20M 10-Q · filed 2022-10-28 | $173.28M 10-Q · filed 2021-11-03 | $220.89M derived: sum of 4 quarters · filed 2023-02-10 | |||
| 2021-06-30 | $49.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $120.80M 10-Q · filed 2022-08-05 | $120.76M 10-Q · filed 2021-07-30 | $168.49M derived: sum of 3 quarters · filed 2023-02-10 | $343.29M derived: sum of 4 quarters · filed 2023-02-10 | |||
| 2021-03-31 | $70.90M 10-Q · filed 2022-05-06 | $70.93M 10-Q · filed 2021-04-30 | $118.59M derived: sum of 2 quarters · filed 2023-02-10 | $293.39M derived: sum of 3 quarters · filed 2023-02-10 | $311.25M derived: sum of 4 quarters · filed 2023-02-10 | |||
| 2020-12-31 | $47.69M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $222.49M derived: sum of 2 quarters · filed 2023-02-10 | $240.35M derived: sum of 3 quarters · filed 2023-02-10 | $259.80M 10-K · filed 2023-02-10 | $259.80M 10-K · filed 2021-02-11 | |||
| 2020-09-30 | $174.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $192.66M derived: sum of 2 quarters · filed 2021-11-03 | $212.11M 10-Q · filed 2021-11-03 | $228.82M derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2020-06-30 | $17.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $37.31M 10-Q · filed 2021-07-30 | $54.02M derived: sum of 3 quarters · filed 2022-02-09 | $78.31M derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2020-03-31 | $19.45M 10-Q · filed 2021-04-30 | $36.16M derived: sum of 2 quarters · filed 2022-02-09 | $60.45M derived: sum of 3 quarters · filed 2022-02-09 | $76.81M derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2019-12-31 | $16.71M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $41.00M derived: sum of 2 quarters · filed 2022-02-09 | $57.36M derived: sum of 3 quarters · filed 2022-02-09 | $75.40M 10-K · filed 2022-02-09 | $75.45M 10-K · filed 2020-02-13 | |||
| 2019-09-30 | $24.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | $40.65M derived: sum of 2 quarters · filed 2020-10-30 | $58.69M 10-Q · filed 2020-10-30 | $74.34M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-06-30 | $16.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $34.40M 10-Q · filed 2020-07-31 | $50.05M derived: sum of 3 quarters · filed 2021-02-11 | $70.96M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-03-31 | $18.04M 10-Q · filed 2020-05-01 | $33.69M derived: sum of 2 quarters · filed 2021-02-11 | $54.60M derived: sum of 3 quarters · filed 2021-02-11 | $84.21M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2018-12-31 | $15.65M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $36.56M derived: sum of 2 quarters · filed 2021-02-11 | $66.17M derived: sum of 3 quarters · filed 2021-02-11 | $95.45M 10-K · filed 2021-02-11 | $95.52M 10-K · filed 2019-02-13 | |||
| 2018-09-30 | $20.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $50.52M derived: sum of 2 quarters · filed 2019-10-31 | $79.80M 10-Q · filed 2019-10-31 | $122.79M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-06-30 | $29.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $58.89M 10-Q · filed 2019-08-01 | $101.88M derived: sum of 3 quarters · filed 2020-02-13 | $129.84M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-03-31 | $29.28M 10-Q · filed 2019-05-01 | $72.26M derived: sum of 2 quarters · filed 2020-02-13 | $100.22M derived: sum of 3 quarters · filed 2020-02-13 | $117.60M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2017-12-31 | $42.98M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $70.94M derived: sum of 2 quarters · filed 2020-02-13 | $88.32M derived: sum of 3 quarters · filed 2020-02-13 | $99.42M 10-K · filed 2020-02-13 | ||||
| 2017-09-30 | $27.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | $45.34M derived: sum of 2 quarters · filed 2018-10-25 | $56.44M 10-Q · filed 2018-10-25 | $56.82M 10-Q · filed 2017-10-30 | $71.22M derived: sum of 4 quarters · filed 2019-02-13 | |||
| 2017-06-30 | $17.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $28.48M 10-Q · filed 2018-07-26 | $28.87M 10-Q · filed 2017-07-28 | $43.27M derived: sum of 3 quarters · filed 2019-02-13 | $57.15M derived: sum of 4 quarters · filed 2019-02-13 | |||
| 2017-03-31 | $11.10M 10-Q · filed 2018-04-27 | $11.16M 10-Q · filed 2017-04-28 | $25.89M derived: sum of 2 quarters · filed 2019-02-13 | $39.77M derived: sum of 3 quarters · filed 2019-02-13 | $55.69M derived: sum of 4 quarters · filed 2019-02-13 | |||
| 2016-12-31 | $14.79M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $28.67M derived: sum of 2 quarters · filed 2019-02-13 | $44.59M derived: sum of 3 quarters · filed 2019-02-13 | $56.56M 10-K · filed 2019-02-13 | ||||
| 2016-09-30 | $13.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-30 | $29.80M derived: sum of 2 quarters · filed 2017-10-30 | $41.77M 10-Q · filed 2017-10-30 | $54.30M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-06-30 | $15.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $27.89M 10-Q · filed 2017-07-28 | $40.42M derived: sum of 3 quarters · filed 2018-02-15 | $49.22M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-03-31 | $11.97M 10-Q · filed 2017-04-28 | $24.50M derived: sum of 2 quarters · filed 2018-02-15 | $33.30M derived: sum of 3 quarters · filed 2018-02-15 | $46.72M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2015-12-31 | $12.53M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $21.32M derived: sum of 2 quarters · filed 2018-02-15 | $34.74M derived: sum of 3 quarters · filed 2018-02-15 | $45.30M 10-K · filed 2018-02-15 | ||||
| 2015-09-30 | $8.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-31 | $22.22M derived: sum of 2 quarters · filed 2016-10-31 | $32.77M 10-Q · filed 2016-10-31 | $47.45M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-06-30 | $13.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | $23.98M 10-Q · filed 2016-08-01 | $38.65M derived: sum of 3 quarters · filed 2017-02-23 | $47.95M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-03-31 | $10.56M 10-Q · filed 2016-05-03 | $25.23M derived: sum of 2 quarters · filed 2017-02-23 | $34.53M derived: sum of 3 quarters · filed 2017-02-23 | $46.23M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2014-12-31 | $14.68M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $23.97M derived: sum of 2 quarters · filed 2017-02-23 | $35.67M derived: sum of 3 quarters · filed 2017-02-23 | $51.20M 10-K · filed 2017-02-23 | ||||
| 2014-09-30 | $9.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | $21.00M derived: sum of 2 quarters · filed 2015-10-30 | $36.52M 10-Q · filed 2015-10-30 | $51.00M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2014-06-30 | $11.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $27.23M 10-Q · filed 2015-08-04 | $41.70M derived: sum of 3 quarters · filed 2016-02-16 | $60.21M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2014-03-31 | $15.53M 10-Q · filed 2015-05-04 | $30.00M derived: sum of 2 quarters · filed 2016-02-16 | $48.51M derived: sum of 3 quarters · filed 2016-02-16 | $50.31M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2013-12-31 | $14.47M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-16 | $32.98M derived: sum of 2 quarters · filed 2016-02-16 | $34.79M derived: sum of 3 quarters · filed 2016-02-16 | $51.39M 10-K · filed 2016-02-16 | ||||
| 2013-09-30 | $18.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $20.32M derived: sum of 2 quarters · filed 2014-11-06 | $36.92M 10-Q · filed 2014-11-06 | $64.97M derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2013-06-30 | $1.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $18.41M 10-Q · filed 2014-07-31 | $46.45M derived: sum of 3 quarters · filed 2015-02-13 | $67.85M derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2013-03-31 | $16.61M 10-Q · filed 2014-05-05 | $44.65M derived: sum of 2 quarters · filed 2015-02-13 | $66.05M derived: sum of 3 quarters · filed 2015-02-13 | $81.59M derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2012-12-31 | $28.05M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | $49.44M derived: sum of 2 quarters · filed 2015-02-13 | $64.98M derived: sum of 3 quarters · filed 2015-02-13 | $71.14M 10-K · filed 2015-02-13 | ||||
| 2012-09-30 | $21.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $36.94M derived: sum of 2 quarters · filed 2013-11-07 | $43.09M 10-Q · filed 2013-11-07 | $52.42M derived: sum of 4 quarters · filed 2014-02-11 | ||||
| 2012-06-30 | $15.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-02 | $21.70M 10-Q · filed 2013-08-02 | $31.03M derived: sum of 3 quarters · filed 2014-02-11 | $41.01M derived: sum of 4 quarters · filed 2014-02-11 | ||||
| 2012-03-31 | $6.16M 10-Q · filed 2013-05-08 | $15.48M derived: sum of 2 quarters · filed 2014-02-11 | $25.47M derived: sum of 3 quarters · filed 2014-02-11 | $35.90M derived: sum of 4 quarters · filed 2014-02-11 | ||||
| 2011-12-31 | $9.33M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-11 | $19.31M derived: sum of 2 quarters · filed 2014-02-11 | $29.75M derived: sum of 3 quarters · filed 2014-02-11 | $34.59M 10-K · filed 2014-02-11 | ||||
| 2011-09-30 | $9.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $20.42M derived: sum of 2 quarters · filed 2012-11-06 | $25.27M 10-Q · filed 2012-11-06 | $39.69M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-06-30 | $10.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $15.28M 10-Q · filed 2012-08-08 | $29.71M derived: sum of 3 quarters · filed 2013-03-01 | $40.54M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-03-31 | $4.85M 10-Q · filed 2012-05-10 | $19.28M derived: sum of 2 quarters · filed 2013-03-01 | $30.11M derived: sum of 3 quarters · filed 2013-03-01 | $39.79M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2010-12-31 | $14.43M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $25.26M derived: sum of 2 quarters · filed 2013-03-01 | $34.94M derived: sum of 3 quarters · filed 2013-03-01 | $38.05M 10-K · filed 2013-03-01 | ||||
| 2010-09-30 | $10.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $20.52M derived: sum of 2 quarters · filed 2011-11-03 | $23.63M 10-Q · filed 2011-11-03 | $31.20M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2010-06-30 | $9.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-09 | $12.80M 10-Q · filed 2011-08-09 | $20.37M derived: sum of 3 quarters · filed 2012-02-22 | $25.13M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2010-03-31 | $3.11M 10-Q · filed 2011-05-06 | $10.69M derived: sum of 2 quarters · filed 2012-02-22 | $15.44M derived: sum of 3 quarters · filed 2012-02-22 | $20.03M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2009-12-31 | $7.58M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $12.33M derived: sum of 2 quarters · filed 2012-02-22 | $16.92M derived: sum of 3 quarters · filed 2012-02-22 | $23.50M 10-K · filed 2012-02-22 | ||||
| 2009-09-30 | $4.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-28 | $9.34M derived: sum of 2 quarters · filed 2010-10-28 | $15.92M 10-Q · filed 2010-10-28 | |||||
| 2009-06-30 | $4.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-03 | $11.16M 10-Q · filed 2010-08-03 | ||||||
| 2009-03-31 | $6.58M 10-Q · filed 2010-05-03 | |||||||
| 2008-12-31 | $32.18M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |